Has Aurora Cannabis Inc. Displaced Canopy Growth Corp. as the Top Pot Stock?

Is Aurora Cannabis Inc. (TSX:ACB) a better buy than Canopy Growth Corp. (TSX:WEED)?

| More on:

On Wednesday, Aurora Cannabis Inc. (TSX:ACB) cleared the last hurdle in its pursuit of purchasing CanniMed Therapeutics Inc. (TSX:CMED), as it received the regulatory approval it needed to proceed. The saga lasted for months, and it had all the drama of a soap opera, and even involved a third wheel in Newstrike Resources Ltd. Aurora’s final bid for CanniMed was $43 a share, which was up from its earlier offer of just $24.

The deal between the two companies would make Aurora the most valuable pot stock on the TSX, ahead of Canopy Growth Corp. (TSX:WEED), which has been synonymous with cannabis legalization and at the forefront of many big developments.

Does the deal make Aurora a better buy than Canopy?

While Aurora has certainly gotten bigger in size, it’s debatable as to whether or not this deal means the stock is a better buy than Canopy.

From a market share perspective, Canopy still has a big edge over Aurora, even with this partnership. In the past four quarters, Canopy’s sales have totaled just under $70 million. By comparison, Aurora’s top line has come in at less than half of that, with just $31 million in sales having been accumulated in the trailing 12 months. While CanniMed’s sales would help bridge the gap, even combined, the two entities fall well short of Canopy’s tally.

If we look at overall profitability, then Aurora certainly has the advantage with the company finishing in the black in three of the past four quarters, while Canopy has only posted a profit in just one of the last four. However, we haven’t seen profitability be a big concern for cannabis investors thus far, especially as we are still in the early growth stages in the industry.

We can also compare the stocks in terms of valuation. With a market capitalization of over $5 billion, Aurora is trading at more than 160 times its sales. Canopy, however, trades at a multiple of just 85. Aurora saw its stock skyrocket amid news that it was looking to buy CanniMed last year, and that has left the share price at a big premium.

Why I still give Canopy the edge

Although Canopy may be passed in terms of market capitalization, the deals and partnerships that it has formed in the past year are what give it an advantage over Aurora and other cannabis stocks. With the company securing some big supply deals with multiple different provinces, that’s going to be a big win when it comes to market share, especially given the restrictions we’re likely to see imposed on advertising in the industry.

One of the big challenges will be how cannabis companies can make consumers aware of their brand in light of the limits on advertising. That’s where Canopy’s position in the industry helps set it apart from its competitors and will give it the name recognition that other stocks simply won’t have.

Although Aurora has seen a lot more hype lately, Canopy has a lot more substance behind it, and that makes it a better investment over the long term.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Investing

Nuclear power station cooling tower
Metals and Mining Stocks

If You’d Invested $1,000 in Cameco Stock 5 Years Ago, This Is How Much You’d Have Now

Cameco (TSX:CCO) stock still looks undervalued, despite a 258% rally. Can the uranium miner deliver more capital gains to shareholders?

Read more »

Businessman holding tablet and showing a growing virtual hologram of statistics, graph and chart with arrow up on dark background. Stock market. Business growth, planning and strategy concept
Dividend Stocks

TFSA Magic: Earn Enormous Passive Income That the CRA Can’t Touch

If you're seeking out passive income, with zero taxes involved, then get on board with a TFSA and this portfolio…

Read more »

Man with no money. Businessman holding empty wallet
Dividend Stocks

2 Stocks Under $50 New Investors Can Confidently Buy

There are some great stocks under $50 that every investor needs to know about. Here’s a look at two great…

Read more »

potted green plant grows up in arrow shape
Stocks for Beginners

3 Growth Stocks I’m Buying in April

These three growth stocks are up in the last year, and that is likely to continue on as we keep…

Read more »

clock time
Tech Stocks

Long-Term Investing: 3 Top Canadian Stocks You Can Buy for Under $20 a Share

These three under-$20 stocks offer excellent buying opportunities for long-term investors.

Read more »

Arrowings ascending on a chalkboard
Energy Stocks

Beat the TSX With This Cash-Gushing Dividend Stock

Canadian Natural Resources stock is well set up to beat the TSX as it continues to generate strong cash flows…

Read more »

think thought consider
Dividend Stocks

Down 10.88%: Is ATD Stock a Good Buy After Earnings?

Alimentation Couche-Tard (TSX:ATD) stock might not be the easy buy-case it once was. Here’s a look at what happened.

Read more »

money cash dividends
Dividend Stocks

TFSA Dividend Stocks: Earn $1,200/Year Tax-Free

Canadian stocks like Fortis are a must-have in your portfolio to earn tax-free yields for decades.

Read more »